228 related articles for article (PubMed ID: 38239785)
1. Epidemiology and antimicrobial resistance trends of
Thomsen J; Abdulrazzaq NM; AlRand H; ; Everett DB; Senok A; Menezes GA; Ayoub Moubareck C
Front Public Health; 2023; 11():1245131. PubMed ID: 38239785
[TBL] [Abstract][Full Text] [Related]
2. Evolving trends among
Thomsen J; Menezes GA; Abdulrazzaq NM; ; Moubareck CA; Senok A; Everett DB
Front Public Health; 2023; 11():1243973. PubMed ID: 38106909
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of vancomycin-resistant enterococci in the United Arab Emirates: a retrospective analysis of 12 years of national AMR surveillance data.
Thomsen J; Abdulrazzak NM; AlRand H; ; Menezes GA; Moubareck CA; Everett DB; Senok A; Podbielski A
Front Public Health; 2023; 11():1275778. PubMed ID: 38089023
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and antimicrobial resistance of
Thomsen J; Abdulrazzaq NM; Nyasulu PS; Al Hosani F; Habous M; Weber S; Jabeen F; ; Menezes GA; Moubareck CA; Senok A; Everett DB
Front Public Health; 2024; 12():1244353. PubMed ID: 38947352
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem resistant
Thomsen J; Abdulrazzaq NM; ; Everett DB; Menezes GA; Senok A; Ayoub Moubareck C
Front Public Health; 2023; 11():1244482. PubMed ID: 38145078
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolates in the Gulf Cooperation Council States: dominance of OXA-23-type producers.
Zowawi HM; Sartor AL; Sidjabat HE; Balkhy HH; Walsh TR; Al Johani SM; AlJindan RY; Alfaresi M; Ibrahim E; Al-Jardani A; Al Salman J; Dashti AA; Johani K; Paterson DL
J Clin Microbiol; 2015 Mar; 53(3):896-903. PubMed ID: 25568439
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of antimicrobial resistance in the United Arab Emirates: the early implementation phase.
Thomsen J; Abdulrazzaq NM; AlRand H;
Front Public Health; 2023; 11():1247627. PubMed ID: 38074700
[TBL] [Abstract][Full Text] [Related]
10. [Risk factors and resistance patterns of invasive
Ge YL; Shan QW; Qiu Y; Zhou SP; Cheng YB; Wang F; Yang JW; Wan CM; Zhu Y; Xu Y; Chen MX; Lin DJ; Zhu CH; Zeng M
Zhonghua Er Ke Za Zhi; 2022 Aug; 60(8):762-768. PubMed ID: 35922185
[No Abstract] [Full Text] [Related]
11. Prevalence of carbapenem-resistant Acinetobacter baumannii from 2005 to 2016 in Switzerland.
Ramette A; Kronenberg A;
BMC Infect Dis; 2018 Apr; 18(1):159. PubMed ID: 29614963
[TBL] [Abstract][Full Text] [Related]
12. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam.
Wareth G; Linde J; Hammer P; Nguyen NH; Nguyen TNM; Splettstoesser WD; Makarewicz O; Neubauer H; Sprague LD; Pletz MW
Int J Antimicrob Agents; 2020 Oct; 56(4):106127. PubMed ID: 32750418
[TBL] [Abstract][Full Text] [Related]
14. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated from three major hospitals in Jordan.
Ababneh Q; Aldaken N; Jaradat Z; Al Sbei S; Alawneh D; Al-Zoubi E; Alhomsi T; Saadoun I
Int J Clin Pract; 2021 Dec; 75(12):e14998. PubMed ID: 34714567
[TBL] [Abstract][Full Text] [Related]
15. Emergence of highly resistant
Thomsen J; Abdulrazzaq NM; Oulhaj A; Nyasulu PS; Alatoom A; Denning DW; Al Dhaheri F; ; Menezes GA; Moubareck CA; Senok A; Everett DB
Front Public Health; 2023; 11():1244358. PubMed ID: 38292390
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant
Chandra P; V R; M S; Cs S; Mk U
Expert Rev Anti Infect Ther; 2022 May; 20(5):721-732. PubMed ID: 34878345
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
Ibrahim ME
Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201
[TBL] [Abstract][Full Text] [Related]
18. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
[TBL] [Abstract][Full Text] [Related]
19. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
[TBL] [Abstract][Full Text] [Related]
20.
Karlowsky JA; Hackel MA; McLeod SM; Miller AA
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0078122. PubMed ID: 36005804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
